HOXA9 has the hallmarks of a biological switch with implications in blood cancers

Laure Talarmain; Matthew A Clarke; David Shorthouse; Lilia Cabrera-Cosme; David Geoffrey Kent; Jasmin Fisher; Benjamin A Hall

HOXA9 has the hallmarks of a biological switch with implications in blood cancers

Laure Talarmain, Matthew A Clarke, David Shorthouse, Lilia Cabrera-Cosme, David Geoffrey Kent, Jasmin Fisher, Benjamin A Hall

Biology

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Nature Communications
Publication status	Accepted/In press - 7 Sep 2022

Access to Document

mpn_submission_Sept22Accepted author manuscript, 79.8 KB

Cite this

@article{c16cee4a4d764d4da555bd87a035709e,

title = "HOXA9 has the hallmarks of a biological switch with implications in blood cancers",

author = "Laure Talarmain and Clarke, {Matthew A} and David Shorthouse and Lilia Cabrera-Cosme and Kent, {David Geoffrey} and Jasmin Fisher and Hall, {Benjamin A}",

year = "2022",

month = sep,

day = "7",

language = "English",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - HOXA9 has the hallmarks of a biological switch with implications in blood cancers

AU - Talarmain, Laure

AU - Clarke, Matthew A

AU - Shorthouse, David

AU - Cabrera-Cosme, Lilia

AU - Kent, David Geoffrey

AU - Fisher, Jasmin

AU - Hall, Benjamin A

PY - 2022/9/7

Y1 - 2022/9/7

M3 - Article

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

ER -